L‐aspartate ameliorates diet‐induced obesity by increasing adipocyte energy expenditure
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Shi-Yao Guo und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Obesity, Energy Metabolism, Diet, High-Fat, Mice, Inbred C57BL. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Ministry of Education of China, National Natural Science Foundation of China, Higher Education Discipline Innovation Project.
Abstract (Originalsprache)
Aims
Obesity always leads to profound perturbation of metabolome. Metabolome studies enrich the knowledge on associations between endogenous metabolites and obesity, potentially providing innovative strategies for the development of novel anti‐obesity pharmacotherapy. This study aims to identify an endogenous metabolite that regulates energy expenditure and to explore its application for obesity treatment. Materials and Methods C57BL/6 mice were fed with a high‐fat and high‐cholesterol (HFC) diet, comprising 60% fat and 1.2% cholesterol, for 12 weeks to induce obesity. Significant metabolites were identified in the livers of both health and obese mice through comparative hepatic metabolomics analysis. Correlation between serum or adipose L‐aspartate level and body weight in obese mice, as well as human body mass index (BMI), was evaluated. In addition, saline or 200 mg/kg L‐aspartate was orally administrated to HFC diet mice and HFC diet‐induced obese mice for 6–7 weeks. Body weight, adipose tissue weight, glucose tolerance and liver damage were assessed to evaluate the effect on obesity prevention and treatment. Comprehensive lab animal monitoring system (CLAMS) and seahorse assay were employed to investigate the regulatory effect of L‐aspartate on energy metabolism in vivo and in vitro, respectively. 3T3‐L1 preadipocytes and murine white adipose tissue (WAT) were utilized to examine the impact of L‐aspartate on adipocyte adipogenesis and lipogenesis and cellular signalling pathway in vitro and in vivo.
Results
L‐aspartate, an approved drug for liver injury and chronic fatigue, was identified as an endogenous inducer of energy expenditure. Serum or adipose L‐aspartate levels were found to be negatively correlated with the severity of obesity in both humans and mice. Administration of L‐aspartate to HFC diet mice led to a significant reduction in body weight, with decreases of 14.5% in HFC diet mice and 8.5% in HFC diet‐induced obese mice, respectively. In addition, the treatment improved related metabolic syndrome (Figure 2 and Figure S3). These therapeutics were associated with enhancements in whole‐body energy expenditure and suppression of adipocyte adipogenesis along with activation of Adenosine 5′‐monophosphate‐activated protein kinase (AMPK) signalling pathway.
Conclusion
L‐aspartate may serve as a novel endogenous inducer of energy expenditure and suppressor of adipogenesis and lipogenesis along with activation of AMPK, thereby offering a promising therapeutic strategy for obesity prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou, China.
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, China.
ORCID-Profile: Shi-Yao Guo, Zhi-Shu Huang
Förderung
- Ministry of Education of China
- National Natural Science Foundation of China
- Higher Education Discipline Innovation Project
- Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program
- Natural Science Foundation of Guangdong Province
- Outstanding Talents of Guangdong Special Plan
- Guangdong Provincial Key Laboratory of Construction Foundation
- Ministry of Education of the People's Republic of China
Zitieren
APA
Guo, S. Y., Hu, Y. T., Rao, Y., Jiang, Z., Li, C., Lin, Y. W., Xu, S. M., Zhao, D. D., Wei, L. Y., Huang, S. L., Li, Q. J., Tan, J. H., Chen, S. B., & Huang, Z. S. (2025). L‐aspartate ameliorates diet‐induced obesity by increasing adipocyte energy expenditure. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16053
Vancouver
Guo SY, Hu YT, Rao Y, Jiang Z, Li C, Lin YW, et al. L‐aspartate ameliorates diet‐induced obesity by increasing adipocyte energy expenditure. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16053
BibTeX
@article{Guo2025,
author = {Guo, Shi-Yao and Hu, Yu-Tao and Rao, Yong and Jiang, Zhi and Li, Chan and Lin, Yu-Wei and Xu, Shu-Min and Zhao, Dan-Dan and Wei, Li-Yuan and Huang, Shi-Liang and Li, Qing-Jiang and Tan, Jia-Heng and Chen, Shuo-Bin and Huang, Zhi-Shu},
title = {L‐aspartate ameliorates diet‐induced obesity by increasing adipocyte energy expenditure},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16053}
}
EUVIMED